Trials in Cincinnati, Ohio
Here are the top 10 medical studies for breast cancer in Cincinnati, Ohio
Popular Filters
Phase 3 Trials
Monoclonal Antibodies
Trastuzumab Deruxtecan for Breast Cancer
Recruiting2 awardsPhase 3
Louisville, Kentucky
This trial is testing a new drug called trastuzumab deruxtecan for patients with advanced breast cancer that hasn't responded to other treatments. The drug works by specifically targeting and killing cancer cells. The study aims to see if this drug helps patients live longer or improves their quality of life compared to other treatments. Trastuzumab deruxtecan has shown significant clinical benefits in treating advanced breast cancer and other similar tumors.
Trials With No Placebo
Monoclonal Antibodies
ONC-392 + Pembrolizumab for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1 & 2
Cincinnati, Ohio
This trial tests ONC-392, an antibody that helps the immune system fight cancer, in patients with advanced or spreading tumors who haven't responded to other treatments. It works by blocking a protein that usually keeps immune responses in check, making it easier for the body to attack cancer cells.
Anti-mitotic Agent
Radium Therapy + Chemotherapy for Metastatic Breast Cancer
Recruiting1 awardPhase 2
Lexington, Kentucky
This trial is testing radium-223 dichloride (a radioactive drug) + paclitaxel (a chemotherapy drug) to see if it's more effective than paclitaxel alone in treating patients with metastatic breast cancer.
Exercise Treatment for Breast Cancer
Recruiting1 awardPhase 1
Indianapolis, Indiana
This trial will test the benefits and risks of aerobic exercise for patients with metastatic breast cancer who are receiving hormone therapy. Researchers think that exercise may help delay the development of resistance to hormone therapy and slow the growth of tumors.
CDK4/6 Inhibitor
Copanlisib + Usual Treatment for Advanced Breast Cancer
Recruiting1 awardPhase 1 & 2
Lexington, Kentucky
This trial is studying the effects of adding copanlisib to the usual therapy of fulvestrant and abemaciclib in treating patients with hormone receptor positive and HER2 negative stage IV breast cancer.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.